000			01706 a2200409 4500
005			20250515115001.0
264		0	_c20080507
008			200805s 0 0 eng d
022			_a1744-8301
024	7		_a10.2217/14796694.4.2.211 _2doi
040			_aNLM _beng _cNLM
100	1		_aHandolias, Despina
245	0	0	_aImatinib as effective therapy for dermatofibrosarcoma protuberans: proof of concept of the autocrine hypothesis for cancer. _h[electronic resource]
260			_bFuture oncology (London, England) _cApr 2008
300			_a211-7 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aAutocrine Communication _xdrug effects
650	0	4	_aBenzamides
650	0	4	_aDermatofibrosarcoma _xdrug therapy
650	0	4	_aEpidermal Growth Factor _xphysiology
650	0	4	_aErbB Receptors _xphysiology
650	0	4	_aHumans
650	0	4	_aImatinib Mesylate
650	0	4	_aInsulin-Like Growth Factor I _xphysiology
650	0	4	_aIntercellular Signaling Peptides and Proteins _xphysiology
650	0	4	_aPiperazines _xpharmacology
650	0	4	_aPlatelet-Derived Growth Factor _xphysiology
650	0	4	_aPyrimidines _xpharmacology
650	0	4	_aReceptor, IGF Type 1 _xphysiology
650	0	4	_aReceptors, Growth Factor _xphysiology
650	0	4	_aReceptors, Vascular Endothelial Growth Factor _xphysiology
650	0	4	_aVascular Endothelial Growth Factor A _xphysiology
700	1		_aMcArthur, Grant A
773	0		_tFuture oncology (London, England) _gvol. 4 _gno. 2 _gp. 211-7
856	4	0	_uhttps://doi.org/10.2217/14796694.4.2.211 _zAvailable from publisher's website
999			_c17906037 _d17906037